Fueling Antitumor Immunity Using Oncolytic Viruses Encoding Metabolic Modulators

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Despite the promising results with current approved immunotherapies, all patients do not have the same level of response, and recent efforts have focused on understanding and avoiding immunotherapy resistance. Our lab and others have recently proposed that the metabolic state of tumor infiltrating lymphocytes, either preexisting or adoptively transferred, can compromise T cell function and consequently antitumor immunity. This suggests that the understanding of metabolic mediators and systemic metabolic disorders can contribute to the improvement of current immunotherapies as well as understanding therapeutic responses. Furthermore, understanding the mechanism of action in metabolic disorders can allow us to harness their inflammatory potential. Leptin affects a wide range of metabolic processes as well as being a pro inflammatory mediator, can be utilized as a means to remodel the metabolic state of the tumor microenvironment, consequently modulating immunotherapy response. Our data shows that leptin overexpressing tumors have increased T cell infiltration compared to control tumors, and these TIL are metabolically and functionally superior. We next wanted to translate tumor-specific expression of leptin into a therapeutic model. Oncolytic viruses are an attractive therapeutic modality promoting tumor specific killing, inducing an anti-tumor immune response, as well as the capacity to deliver genetic payloads potentially enhancing their anti-tumor activity. We designed an oncolytic Vaccinia virus that expresses leptin and used it to treat aggressive genetically-induced melanomas. While wild-type oncolytic Vaccinia showed some response, leptin-engineered Vaccinia had superior therapeutic efficacy inducing complete regressions in 30% of mice. TIL from these tumors have improved T cell infiltration and function. Single cell RNAseq and TCR sequencing immune infiltrates revealed the influx of new T cells by vaccinia while leptin-expressing virus showed specific clonal expansion. Most importantly we observed a strong memory response when complete responders where rechallenged with tumor cells. Taken together, these data suggest that understanding metabolic modulators in metabolic disorders, like leptin, can inform on therapeutic outcomes as well as taking advantage of these molecules for novel therapeutic modalities.

Learning Objectives:

1. Understand the role metabolic pressures play on the function of tumor infiltrating lymphocytes.

2. Identify metabolic mediators as potential therapeutic targets.

3. Learn about oncolytic viruses and their mechanisms of action as immunotherapeutic modalities.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
AUG 24, 2021 11:00 AM PDT
C.E. CREDITS
AUG 24, 2021 11:00 AM PDT
Date: August 24, 2021 Time: 11:00am (PDT), 1:00pm (EDT) Electron-based dissociation mechanisms have shown great promise for advanced characterization of biomolecules. However, routine adopti...
Loading Comments...
Show Resources